Harrow, Inc. Effective Tax Rate
Harrow, Inc. (HROW) reported Effective Tax Rate of -275.66% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-02
- Harrow, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-03-31 was 0.00%.
- Harrow, Inc. effective income tax rate reconciliation, percent for the quarter ending 2024-03-31 was -0.11%, a 102.64% decline year-over-year.
- Harrow, Inc. effective income tax rate reconciliation, percent for the quarter ending 2023-09-30 was -53.96%.
- Harrow, Inc. effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was 4.16%.
- Harrow, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was -275.66%.
- Harrow, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was -0.93%.
- Harrow, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was -2.88%.
- Harrow, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was -0.53%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -275.66% 10-K · filed 2026-03-02 | |||||
| 2025-06-30 | 0.00% 10-Q · filed 2025-08-11 | |||||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-08 | |||||
| 2024-12-31 | -0.93% 10-K · filed 2026-03-02 | |||||
| 2024-09-30 | -2.95% 10-Q · filed 2024-11-14 | |||||
| 2024-06-30 | -3.38% 10-Q · filed 2025-08-11 | 3.38% 10-Q · filed 2024-08-07 | ||||
| 2024-03-31 | -0.11% 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | -2.88% 10-K · filed 2026-03-02 | |||||
| 2023-09-30 | -53.96% 10-Q · filed 2023-11-13 | -8.81% 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | -2.71% 10-Q · filed 2024-08-07 | |||||
| 2023-03-31 | 4.16% 10-Q · filed 2024-05-13 | |||||
| 2022-12-31 | -0.53% 10-K · filed 2024-03-19 | -0.43% 10-K · filed 2023-03-23 | ||||
| 2022-09-30 | -0.54% 10-Q · filed 2023-11-13 | -0.50% 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 0.46% 10-Q · filed 2023-08-09 | |||||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | -0.74% 10-K · filed 2023-03-23 | |||||
| 2020-12-31 | -0.11% 10-K · filed 2022-03-10 | |||||
| 2019-12-31 | -6.73% 10-K · filed 2021-03-08 | |||||
| 2018-12-31 | -0.44% 10-K · filed 2020-03-13 | |||||
| 2017-12-31 | 7.27% 10-K · filed 2019-03-12 | 7.26% 10-K · filed 2018-03-08 | ||||
| 2016-12-31 | 0.54% 10-K · filed 2018-03-08 | |||||
| 2015-12-31 | -0.03% 10-K · filed 2017-03-21 | |||||
| 2014-12-31 | -0.03% 10-K · filed 2016-03-23 | |||||
| 2013-12-31 | 0.00% 10-K · filed 2015-03-12 | |||||
| 2012-12-31 | 2.77% 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |